Pma 3 review - Study guides, Class notes & Summaries

FDA Time Frames (Device) RAC Exam Questions and Answers 100% Solved Facility Registration - Devices - within XX days of application or manufacturing 30 days Facility Re-Registration - Devices, Drugs & Biologics Annual GLP & GCP Record Retention 5 Years - from application or 2 Years - from approval or termination date IND/IDE (GCP) - Progress Report - Reporting requirements Sponsor report to FDA & IRB Investigator reports to Sponsor & IRB Annual - 60 days from anniversary IND & IDE - time al...

US RAC Review Questions RAPS Modules 2024 with complete solution In which situation is an IND not required? A) You intend to conduct a clinical trial with an investigational new drug B) You intend to conduct a clinical trial with an approved drug to support a marketing application for a new indication C) You intend to collect blood samples from subjects to look for biomarkers or pharmacogenetic information D) You intend to conduct a clinical trial using 2 of your approved drugs in a new ...

A medical device manufacturer is preparing a submission that requires a Declaration of Conformity with design control requirements. What type of submission is the manufacturer preparing to submit to FDA? 0 A PMA 1 A Special 510(k), 2 An Individual Device Exemption (IDE), 3 An Annual Report for a PMA - ANSWER-A Special 510(k) A company wishes to expand existing labeling for a medical device to include a new indication for use. What action should the regulatory professional take FIRST? - ...

Number of Days for review of PMA - ANSWER-180 days How many routes to a PMA? - ANSWER-3 Routes: 1. 2 3 What makes a PMA unique (vs 510k)? - ANSWER--Must include section on clinical investigations on human subjects -Must include a seperate volume on QS for review by CDRH/OC (office of compliance) -Includes a premarket QMS inspection -Sponsor should update the PMA periodically during review (if a big update, might reset the clock) *SSED vs 510k summary *no substantial equivalence with...

A company is performing routine site monitoring of its pivotal clinical study for a blood sugar meter and finds one site has not consented one-third of its subjects properly . What is the FIRST thing the company needs to do? A.Stop the entire study B. Inform FDA and ask for guidance C. Re-train the study staff, including the principle investigator D. Re-consent all improperly consented subjects - correct answer D Re-consent all improperly cons...

US RAC Review Questions RAPS Modules Exam Questions And Answers In which situation is an IND not required? A) You intend to conduct a clinical trial with an investigational new drug B) You intend to conduct a clinical trial with an approved drug to support a marketing application for a new indication C) You intend to collect blood samples from subjects to look for biomarkers or pharmacogenetic information D) You intend to conduct a clinical trial using 2 of your approved drugs in a new c...

In which situation is an IND not required? A) You intend to conduct a clinical trial with an investigational new drug B) You intend to conduct a clinical trial with an approved drug to support a marketing application for a new indication C) You intend to collect blood samples from subjects to look for biomarkers or pharmacogenetic information D) You intend to conduct a clinical trial using 2 of your approved drugs in a new combination - C) You intend to collect blood samples from subjects ...

PMK-EE E6 Career Information questions and correct answersThe DoN sets requirements for advancement, but does NOT guarantee advancement. Advancement is ultimately determined by what factor? Vacancy Establishing advancement quotas is the responsibility of what office? Not CNO and SECNAV A Sailor's eligibility for advancement to a higher paygrade is determined by what individual? Commanding Officer All of the following types of publications can be listed on bibliographies ...

A medical device manufacturer is preparing a submission that requires a Declaration of Conformity with design control requirements. What type of submission is the manufacturer preparing to submit to FDA? 0 A PMA 1 A Special 510(k), 2 An Individual Device Exemption (IDE), 3 An Annual Report for a PMA - A Special 510(k) A company wishes to expand existing labeling for a medical device to include a new indication for use. What action should the regulatory professional take FIRST? - Contact t...

SOCRA CCRP Exam (2023/2024) Rated A Timeline of Historical Events Nuremberg Code 1947, Declaration of Helsinki 1964, Belmont Report 1979 The Three Principles of the Belmont Report respect for persons, beneficence, justice Application of Respect for Persons informed consent (autonomy, choose for themselves) Application of Beneficence risk/benefit analysis Application of Justice appropriate selection of patients (equality) Language Level ICF 6th-8th grade 8 basic elements of ICF 1. purpose, ...